LAS VEGAS, May 1, 2007 (PRIME NEWSWIRE) -- Samaritan Pharmaceuticals Inc. (AMEX:LIV), a developer of innovative drugs, announced today, it will present its late-stage preclinical drug candidates at the BIO International Convention 2007 in Boston, MA, on May 8, 2007 at 3 PM EDT, Room D, in the Business Forum. Samaritan will highlight its novel Alzheimer's drug, Caprospinol (SP-233) as the closest to potentially enter Phase I human clinical trials, as well as present its acute coronary drug candidate (SP-1000) and its oral hepatitis C drug candidate (SP-10T1).
